Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medicare Part D Plan ‘Instability’ May Prompt Demands For More Drug Price Concessions
Nov 19 2025
•
By
Cathy Kelly
Be careful what you wish for? Manufacturer-supported spending cap in Part D may become a liability.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from Government Payers